CANCER RESEARCH UK’s Centre for Drug Development (CDD), in collaboration with the Rising Tide Foundation, a Swiss-based non-profit organisation which funds innovative cancer trials, today (TUESDAY) announce a new trial at The Royal Marsden and University College London that could revolutionise how children with one of the deadliest forms of cancer are diagnosed. The news falls in Children’s Cancer Awareness Month, which runs throughout September.
A technique developed by astronomers seeking a clear view of distant objects in space is being intensively studied as a new approach to measuring and correcting visual abnormalities. The October issue of Optometry and Vision Science, official journal of the American Academy of Optometry, is a theme issue devoted to research on wavefront refraction and correction. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
AdvancedCath, a portfolio company of Inverness Graham Investments, announced on September 9, 2014 it significantly expanded its outsourced medical device manufacturing platform by acquiring LSA Laser located in Plymouth, MN. LSA Laser brings state of the art laser welding and micro machining capabilities to complement AdvancedCath’s existing catheter and guidewire manufacturing business.
The Spectranetics Corporation today announced that Eric Dippel, MD, at Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, presented findings from the EXCITE ISR clinical trial proving Spectranetics' laser atherectomy devices, used with PTA (also known as balloon angioplasty), are clinically superior to PTA alone in both safety and efficacy, triggering a new standard in cardiovascular care.
Research and Markets has announced the addition of the "Research on Laser Medical Cosmetology Market in China, 2014-2018" report to their offering.
El Segundo optometrist Dr. Michael Hansen is proud to announce a new El Segundo location for Advanced Eye Care. The new facility allows the practice to serve a larger geographic area and bring new services to patients.
One thing leads to another, especially in research. When Stony Brook University School of Medicine scientists developed a new method to measure how cocaine disrupts blood flow in the brains of mice, doctors and researchers got a way to form a clearer picture of how drug abuse affects the brain. But the quantitative imaging technique can also be applied to other disease diagnoses and treatments as well, including cancer.
ProNova Solutions and medPhoton announced today that they have agreed to form an exclusive partnership that will merge leading edge pencil beam IMPT and innovative integrated imaging into a unique next generation offering for the proton therapy market.
IMRIS Inc. ("IMRIS" or the "Company") today announced that the Company's InSituTM wireless coil and Monteris NeuroBlate® laser ablation system have been used together for the first time at a leading United States neuroscience center. This combination brought improved visualization and workflow in removing a patient's low-grade glioma brain tumor inside a VISIUS® Surgical Theatre.
Spectra254, a developer of high-power, easy-to-use, affordable UVC light decontamination systems, has released a recent study by Johns Hopkins Medicine that reports that Spectra254’s Spectra 1000 Series of UV light decontamination system is highly effective in killing three major healthcare-acquired pathogens recently named by the Center for Disease Control as urgent or serious public health threats.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.